Revance Therapeutics shares owned by Amalgamated Bank
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Amalgamated Bank
from 13F filings
Historical chart of Amalgamated Bank investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Amalgamated Bank consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Amalgamated Bank
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $14k | 2.8k | 5.07 |
| 2023-12-31 | $103k | 12k | 8.76 |
| 2023-09-30 | $144k | 13k | 11.44 |
| 2023-06-30 | $318k | 13k | 25.27 |
| 2023-03-31 | $368k | 11k | 32.25 |
| 2022-12-31 | $246k | 13k | 18.43 |
| 2022-09-30 | $313k | 12k | 26.97 |
| 2022-06-30 | $153k | 11k | 13.84 |
| 2022-03-31 | $223k | 11k | 19.51 |
| 2021-12-31 | $202k | 12k | 16.35 |
| 2021-09-30 | $349k | 13k | 27.84 |
| 2021-06-30 | $393k | 13k | 29.65 |
| 2021-03-31 | $227k | 8.1k | 27.96 |
| 2020-12-31 | $250k | 8.8k | 28.36 |
| 2020-09-30 | $221k | 8.8k | 25.18 |